• More good research for MM

    Asked by WNMyeloma on Monday, December 9, 2019

    More good research for MM

    CAR T-Cell Therapy on the Horizon for R/R Multiple Myeloma

    ORLANDO, Florida — Treatment with chimeric antigen receptor (CAR) T cells may soon find its way into the treatment landscape of relapsed and/or refractory multiple myeloma (RRMM). This would be a new indication, as so far these novel therapies are approved for use in certain types of lymphoma and leukemia.


    1 Answer from the Community

    • MiriamMarino's Avatar

      It is my understanding that CAR T Cell therapy might be approved by FDA for treatment for relapse MM by the end of the year 2020.

      about 1 year ago

    Help the community by answering this question:

    Create an account to post your answer Already have an account? Sign in!

    By using WhatNext, you agree to our User Agreement, and Privacy Policy

    Read and answer more multiple myeloma questions.  Also, don't forget to check out our Multiple Myeloma page.